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Seroprevalence of Human Herpesvirus 8 among Zambian Women of
Childbearing Age without Kaposi’s Sarcoma (KS) and Mother-Child Pairs with
KS
Jun He, Ganapati Bhat, Chipepo Kankasa,
Chifumbe Chintu, Charles Mitchell, Wenjing Duan,
and Charles Wood

School of Biological Sciences, University of Nebraska, Lincoln,
Nebraska; Department of Pediatrics, University Teaching Hospital,
Lusaka, Zambia; Department of Pediatrics, University of Miami
School of Medicine, Miami, Florida

The seroprevalence of human herpesvirus 8 (HHV-8) among a group of Zambian women
of reproductive age and among mother-child pairs in which either one of them has Kaposi’s
sarcoma (KS) was determined. A cross-sectional group of 378 pregnant women was randomly
recruited into the study, and 183 (48.4%) had HHV-8 antibodies. Among the human immunodeficiency virus (HIV)-1–infected women, 51.1% were HHV-8–seropositive, whereas of HIV1–negative women, 47.3% were HHV-8–seropositive. In addition, 21 women index patients
with KS and 5 young children index patients with KS were studied. All children with KS had
mothers who were HHV-8–seropositive, while not all children whose mothers had KS were
infected with HHV-8. Our study suggests that there is a high HHV-8 seroprevalence among
Zambian women, and the rate is almost the same in HIV-1–positive and –negative women.
This high seroprevalence may be a contributing factor toward the increased frequency of KS
in this population.

Kaposi’s sarcoma (KS) is a soft tissue tumor commonly
found in persons with AIDS and iatrogenically induced immune
deficiencies [1]. Before the AIDS era, it was known as a rare
tumor-like lesion of elderly men from the Mediterranean region
and geographic pockets of equatorial Africa. As the human
immunodeficiency virus (HIV) epidemic progresses in Africa,
the proportion of women and children with AIDS-associated
KS is steadily rising, in contrast to the Western world, where
AIDS-associated KS is commonly observed in HIV-1–infected
homosexual men [2, 3].
Zambia lies in the southern outlying regions of the African
tumor belt overlying eastern Zaire, Uganda, Burundi, and
Rwanda. Before the HIV epidemic, epidemic KS was uncommon in Zambian adults and was rarely seen in children. Before
1983, the male-to-female ratio was 10–15:1. A significant rise
in the incidence of adult KS was observed beginning in 1983
and coincided with the advent of the HIV epidemic. In parallel
to the increase in the incidence of KS in women (male-to-female
ratio dropping to 1.3:1 by 1996), a 10-fold increase in the incidence of pediatric KS has been observed. It has evolved from
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negligible occurrence, of 0%–2%, in the early 1980s to constituting 20%–25% of all pediatric malignancies in 1992 [4].
A novel human herpesvirus 8 (HHV-8), also known as the
KS-associated herpesvirus, is being constantly detected in biopsy samples from patients with all types of KS (AIDS-associated, endemic or African, and classical or sporadic) [5]. This
finding correlates with a high HHV-8 seroprevalence found in
HIV-seropositive homosexual men and fits in with the high
incidence of KS in this population. However, it does not rule
out the possibility that HHV-8, like other herpesviruses, is
widely distributed and may be a mere passenger in these lesions.
HHV-8 DNA has also been found in circulating peripheral
mononuclear cells (PBMC; mostly of B cell lineage) and hyperplastic lymph nodes of immune-competent persons,
strengthening the hypothesis that HHV-8 may establish persistent infection without inducing clinically evident disease [6].
HHV-8 has also been detected in saliva, PBMC, prostate, bone,
and nerve tissue of AIDS patients with or without KS [7, 8].
The pathogenic importance of HHV-8 has been further
strengthened by studies demonstrating that the presence of
HHV-8 in PBMC of HIV-positive persons predicts the subsequent appearance of KS lesions, and seroconversion to positivity for HHV-8 antibodies predates the appearance of KS
lesions [9, 10].
In a decade of increasing KS in children in Zambia, no study
has shown how children acquired this disease. If HHV-8 is
indeed the putative agent, then when and how do children
become infected, and have they acquired the infection vertically
or horizontally? The rise in pediatric KS could be related to
the increase in HIV and HHV-8 infections in women. To determine the seroprevalence of HHV-8 in women and whether
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HHV-8 infection is correlated with HIV-1 infection, we tested
for anti–HHV-8 antibodies in a cohort of Zambian pregnant
women (both with and without HIV-1).

Materials and Methods
Patient population.
The first group, pregnant women aged
15–45 years, all Lusaka residents, were recruited from the Antenatal
Clinic at the University Teaching Hospital in Lusaka, Zambia. The
first 25 women attending the Antenatal Clinic were invited to a
group discussion led by a nurse-midwife HIV counselor who explained the aims of the study in English and local languages, and
patients were allowed to ask questions. Those who were interested
in participating in the study received individual pre-HIV test counseling. Blood was drawn from a peripheral vein (antecubital fossa),
and serum was separated by centrifugation.
The second group, women aged 15–45 years with a confirmed
histopathologic diagnosis of KS, were recruited from the KS section
of the Dermatovenerology Clinic. Pre– and post–HIV test counseling and testing were done. The women were encouraged to bring
their children aged !10 years for blood sampling. The third group,
children aged 0–14 years with a confirmed histopathologic diagnosis of KS, were recruited from the Pediatric Oncology Clinic.
Their parents were counseled, and blood was taken from both the
mother and child for testing. Remaining sera from all patients was
frozen and shipped to the University of Nebraska for detection of
HHV-8 antibodies by IFA.
HIV serology test. Two HIV-1 rapid tests (Capillus and RPD;
Cambridge Biotechnology, Galway, Ireland) were done the same
day, and only discordant results were confirmed by Western blot.
Individualized HIV post-test counseling was done regardless of
HIV serostatus.
IFA for HHV-8 antibodies. IFA was done with BCBL-1 cells
(Epstein-Barr virus–negative, HHV-8 chronically infected B cell
lines from body cavity lymphoma expressing HHV-8 latent antigens; obtained from D. Ganem, via NIH AIDS repository) [11].
The assay was done by procedures described by Lennette et al. [12]
with minor modifications. Cells were induced into a lytic cycle with
20 mg/mL tetradecanoyl phorbol ester acetate (TPA) for 3 days
before they were harvested. About 104 cells were spotted, dried,
and fixed onto each well of a 12-well slide. For IFA, induced cells
were first incubated with patient serum samples diluted to 1:10 and
1:40 for 30 min at 377C, followed with mouse anti-human IgG1,
IgG2, and IgG3 and then with fluorescein-conjugated anti-mouse
antibodies. The samples were then counterstained with 0.004%
Evans blue for 5 min at room temperature to suppress nonspecific
background and observed under a fluorescence microscope. Only
samples with titers of ≥1:40 were considered positive. All positive
samples were tested with TPA-induced HHV-8–negative B lymphoma cells (D6) as control. Each sample was tested twice at varying dilutions and was scored by two laboratory workers independently. The samples were also tested by a more traditional direct
IFA procedure using fluorescein-conjugated goat anti-human antibody as second antibody. Only samples with titers of ≥1:100 were
considered positive.
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Results
This was a cross-sectional seroprevalence study carried out
over a 6-week period during the first half of 1997. The objectives
of this pilot study were to determine the seroprevalence of
HHV-8 in a population of pregnant Zambian women and to
establish whether there is concordant seropositivity among
mother-child pairs, in which either one of them has KS. The
cohort consisted of 3 groups: Pregnant women without KS,
women with KS, and children with KS. For the first group,
378 pregnant women without KS were recruited. Among them,
275 were HIV-1–seronegative and 103 were HIV-1–seropositive.
A total of 183 (48.4%) were found to have an HHV-8 titer of
≥1:40 by IFA (table 1). The frequency of HHV-8 seropositivity
in the HIV-negative group was 47.3%, quite similar to that of
the HIV-positive group, which had a seroprevalent rate of
51.1% for HHV-8. All positive samples were tested on an HHV8–negative B lymphoma cell line and were found to be negative.
To further confirm the high seroprevalence rate in the studied
population, the samples were also tested in parallel with a more
traditional direct IFA technique using fluorescein-conjugated
goat anti-human antibody as the second antibody. All previously positive samples were also found to be positive (≥1:100
dilution) by this traditional direct IFA. In addition, ∼10% of
the negative samples were found to be weakly positive at 1:
100. Since this could not be confirmed by the indirect IFA, we
considered this to be background.
The presence of anti–HHV-8 was also determined in the second and third groups of patients, women with KS and children
with KS, respectively. Twenty-one women with KS and 5 young
children with KS were studied. The results are summarized in
table 2. We found HHV-8 antibodies in all except 2 KS patients
(patients 13 and 14, table 2). These 2 patients may have antibody titers below the detection limit by our IFA. Among children from the 7 women with KS who had children (table 2),
those from 3 mothers were found to be positive; however, the
1-month-old infant (daughter of patient 6) could have acquired
maternal antibodies. These data suggest that not all HHV-8–
seropositive women will have children who are also infected.
In addition, we cannot exclude the possibility that some children have acquired infection from their mothers horizontally,
and even if HHV-8 can be transmitted vertically, not all pregnancies will lead to transmission. This may be similar to HIV1, which has a 30% vertical transmission rate. In contrast,
among the 5 children with KS who were tested for HHV-8
antibodies (children 1–5), all 3 surviving mothers were infected
Table 1. HHV-8 seroprevalence in Zambian women of childbearing
age without KS.
a

HIV–positive
HIV–negative
Total
a

HHV-8–positive

HHV-8–negative

Total

53 (51.1%)
130 (47.3%)
183 (48.4%)

50
145
195

103
275
378

HIV-1 seroprevalence is ∼27% in general female population in Zambia.
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Table 2. HHV-8 seroprevalence in Zambian women and children with clinical KS.

Age group, no.

Seropositivity

Sex/age
(years)

Clinical data

HHV-8

HIV

skin lesions, LAD
skin lesions
skin & oral lesions, LAD
skin lesions
skin & oral lesions, LAD
skin & oral lesions
oral lesions
skin lesions, LAD
skin & oral lesions, LAD

1
1
1
1
1
1
1
1
1

ND
1
1
ND
1
1
1
1
ND

Adult
1
2
3
4
5
6
7
8
9

F/25
F/26
F/33
F/31
F/32
F/28
F/46
F/31
F/35

KS
KS
KS
KS
KS
KS
KS
KS
KS

10

F/32

KS skin lesions, LAD

1

1

11
12
13
14
15
16
17
18
19
20
21
Children
1

F/33
F/18
F/36
F/20
F/27
F/27
F/26
F/19
F/17
F/34
F/36

KS skin lesions, LAD
Skin lesions, LAD
KS oral lesions
KS, LAD
KS, LAD
KS skin & oral lesions,
KS skin & oral lesions,
KS skin & oral lesions,
KS skin & oral lesions,
KS skin lesions, LAD
KS skin lesions

1
1
2
2
1
1
1
1
1
1
1

1
1
ND
ND
ND
1
1
1
1
1
1

M/5

KS skin lesions, LAD

1

ND

2
3
4
5

M/12
M/4.5
M/8
F/8

Oral KS lesions, emaciated, LAD
LAD
KS skin lesions, LAD, carditis
KS

1
1
1
1

1
1
1
1

2
1
2
2
2
1

ND
ND
ND
ND
ND
ND

LAD
LAD
LAD
LAD

Control (clinically normal mother/infant pairs)
1
M/1
Normal
2
F/1
Normal
3
F/1
Normal
4
F/1
Normal
5
F/1
Normal
6
M/8
Normal
NOTE.

Seropositivity
Relatives

HHV-8

HIV

Daughter (5 yr)

2

5

Daughter (1 m)
Son (6 yr)
Daughter (1 yr 8 m)
Husband
Son (5 yr)
Son (3 yr)
Daughter (5 yr)

1
1
2
1
1
2
2

1
2
2
ND
2
2
1

Daughter (5 yr)

2

1

Mother
Sister (7 yr)
Mother (deceased)
Mother
Mother
Mother (deceased)
Father

1
2

ND
2

1
1

1
1

1

1

Mother
Mother
Mother
Mother
Mother
Mother
Sister (6 yr)

2
1
2
2
2
1
1

ND
ND
ND
ND
ND
ND
ND

ND, not determined; LAD, lymphadenopathy; yr, years; m, months; 5, weak positive.

with HHV-8. Interestingly, patient 1, the 5-year-old, has a 7year-old sister who is HHV-8–negative. Our preliminary results
thus showed that not all HHV-8–positive mothers will have
children with HHV-8, but all HHV-8–infected young children
or infants have HHV-8–positive mothers.
As control, we have also tested randomly 6 child-mother
pairs that were all clinically normal. Two of the children were
found to be positive, and both of them have seropositive mothers (table 2). One of them, a 1-year-old baby (control 2), could
have acquired maternal antibodies passively.

Discussion
To our knowledge, this is the first report of a survey for
HHV-8 infection in a well-characterized cohort from an African
country with a high incidence of KS in both women and children. We have chosen pregnant women as our study group, as

they are usually used as a sentinel population for monitoring
the trends in sexually transmitted diseases, including AIDS. The
study of this group of women for HHV-8 seroprevalence will
also enable us to determine whether HHV-8 infection in the
heterosexual female population is also correlated with HIV-1
seropositivity, as seen in the male homosexual population. Our
results suggest that there is a high HHV-8 seroprevalence in
this population. Almost 50% of pregnant women without KS
in our study had HHV-8 antibodies. This high seropositive rate
is in agreement with previous studies that used sera with no
accompanying clinical information from other African countries where HHV-8 seroprevalences of 30%–100% have been
reported [13, 14]. This high seroprevalence may also reflect epidemiologic characteristics of KS in different geographic regions
of the world, such as those seen in an Italian cohort, which
has high incidence of classical KS [13, 15]. The correlation
between HHV-8 seroprevalence and KS supports the notion
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that HHV-8 plays an important role in KS development. The
HIV seroprevalence of 27% found in our study correlates with
urban high HIV seroprevalence of 20%–30% among Zambian
women of childbearing age. The fact that the HHV-8 seroprevalence is similar in both HIV-positive and HIV-negative
populations suggests that infection by HHV-8 is independent
of HIV, and HIV infection did not predispose infection by
HHV-8 and vice versa. However, given the high HHV-8 seroprevalence and the much lower incidence of KS in normal
women, it is likely that HHV-8 infection alone may not be
enough for KS development. The fact that all KS patients are
HIV-positive confirms that KS in this population is epidemic
(AIDS-related), and infection with HIV or immune suppression
may be a necessary prerequisite for clinical expression of KS
in this latently infected population.
Our HHV-8 seroprevalence data among Zambian women of
childbearing age has important implications. This may explain
why in Zambia, in contrast to the Western world, HIV-positive
women often develop KS. The high HHV-8 seroprevalence
among women of childbearing age may be linked to the rising
incidence of KS in Zambian infants and young children. While
epidemiologic features suggest the involvement of a sexually
transmissible agent, KS in children points to a nonsexual mode
of transmission, and if HHV-8 is indeed the putative agent,
then like other herpesviruses, it can be horizontally transmitted
from mother to child. KS has been reported in a 2-week-old
infant [16], preliminary data from Kasolo et al. [17] have identified HHV-8 in a small number of infants and children, and
our preliminary data have demonstrated that young children
with KS were also infected with HHV-8.
Our seroprevalence studies on a limited number of motherinfant pairs also demonstrated that all HHV-8–positive children
had HHV-8–seropositive mothers, but we cannot make definite
conclusions at this stage because the cohort under study was
small, and it is possible that the mothers could have become
infected by HHV-8 subsequent to the children’s birth. We propose to expand on these initial observations to a much larger
cohort. With an estimated HIV seroprevalence of ∼25% and
HHV-8 seroprevalence of almost 50% among the Lusaka urban
obstetrical population, many of these women and their offspring may develop KS. Therefore, it is of utmost importance
to continue follow-up on these women and determine whether
HHV-8 can be transmitted from mother to child.
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